Supply 99% CAS 656247-18-6 Nintedanib Esylate Powder

Details:

                                                                                       Supply 99% CAS 656247-18-6 Nintedanib Esylate Powder

Nintedanib is the first approved drug for the management of idiopathic pulmonary fibrosis (IPF), a rare but often fatal lung disease. Nintedanib 
is believed to exert its mechanism of action by inhibiting multiple receptor tyrosine kinases, including those that have been implicated in the
pathogenesis of IPF (i.e., fibroblast growth factor receptor, platelet-derived growth factor receptor, and vascular endothelial growth factor
receptor). Nintedanib also inhibits nonreceptor tyrosine kinases, although the contribution of this inhibition in the efficacy of the drug is unknown.



Julong Bio-Tech Co., Ltd. is located in Xi'an City, Shaanxi Province, China. It is a biotechnology enterprise engaged in the research,
development,production and sales of animal and plant extracts, cosmetics, pharmaceutical raw materials and intermediates. The company has
complete experimental facilities. And advanced testing instruments  ensure the stability of product quality from all aspects. The company has
a complete sales service system, the products are exported to countries all over the world, and have won a good international reputation with
excellent quality and excellent service.

The company has been adhering to the basic principles of "integrity, quality, service, and win-win" to serve customers, constantly strict
requirements, set goals, and implement win-win development.